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Abstract Mammalian glucosamine 6-phosphate deaminase
(GNPDA) was first detected in hamster spermatozoa. To further
elucidate its role, we have cloned mouse GNPDA and produced a
polyclonal rabbit anti-GNPDA antibody. This antibody recog-
nized a 33 kDa protein in soluble extracts from mouse brain,
liver, kidney, muscle, ovary, testis and sperm. Immunofluorescent
analysis of the localization of GNPDA in male reproductive
tissue revealed its presence in spermatids and in spermatozoa. In
spermatids, GNPDA localized close to the developing acrosome
vesicle and in spermatozoa close to the acrosomal region.
Following the induction of the acrosome reaction, GNPDA
fluorescence in spermatozoa was either reduced or GNPDA was
absent. These data suggest that GNPDA might play a role in the
acrosome reaction.
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1. Introduction
An initial element of mammalian fertilization is the activa-
tion of the oocyte and this process is dependent on the sperm
cell and its ability to induce intracellular Ca2 oscillations [1].
It is now accepted that an oocyte activating capacity is present
in sperm cytosol from a variety of species [2^5]. Recently, a
cytosolic sperm factor from hamster spermatozoa was identi-
¢ed, which seemed to correlate with the ability of extracts to
cause calcium oscillations and activation when injected into
mouse oocytes [6]. This factor, named oscillin, showed a high
sequence homology to bacterial glucosamine 6-phosphate de-
aminase (GNPDA). Initially only found to be present in ham-
ster testis and spermatozoa [6], Wolosker et al. [7] reported a
ubiquitous distribution of mammalian (rat) GNPDA by
Northern and Western blot analysis. Further, these authors
showed that recombinant as well as puri¢ed GNPDA failed to
induce calcium oscillations when injected into mouse eggs and
similar data were recently reported by others [8,9]. Thus the
role of GNPDA in mammalian reproductive tissue is still
under investigation.
This work aimed towards further understanding of the role
of GNPDA in mouse spermatozoa. We cloned mouse
GNPDA and produced anti-GNPDA antiserum which al-
lowed the localization of GNPDA by immuno£uorescence
analysis in mouse testis and in spermatozoa before and after
induction of the acrosome reaction.
2. Materials and methods
2.1. Cloning and sequencing of mouse GNPDA
A 550 bp GNPDA fragment was cloned from a mouse testis phage
library (Stratagene, La Jolla, CA, USA) by polymerase chain reaction
(PCR) using PCR primers designed according to published sequences
[6] as follows: upstream primer, 5P-ACC TTC AAC ATG GAC
GAG-3P ; downstream primer, 5P-AGT CCA CAT ATG GTT CAC-
3P. Screening by plaque-lift ¢lter hybridization was performed with the
PCR fragment labelled with digoxigenin by the random primed meth-
od (High prime kit, Boehringer Mannheim, Germany). Positive clones
were harvested and rescreened twice. From the ¢nal screen we isolated
¢ve individual plaques which were treated with helper phage for ex-
cision of the clone in pBluescript. Restriction analysis showed that all
cloned inserts had the same size and similar restriction patterns. One
clone was chosen for nucleotide sequence analysis. An automated
sequencer (A.L.F. Express DNA Sequencer, Amersham Pharmacia
Biotech, Freiburg, Germany) and a cycle sequencing protocol (Cycle
Sequencing Kit, Amersham Pharmacia Biotech) were used according
to the manufacturer’s recommendations and using primer-speci¢c
modi¢cations. All sequences were recon¢rmed by forward and reverse
sequencing.
2.2. Production of polyclonal antibody
The 550 bp fragment used for screening the phage library was
subcloned in frame into pThioA expression vector (His-Patch Thio-
Fusion Expression System, Invitrogen, De Schelp, The Netherlands).
Expression of a fusion protein was performed according to the in-
structions of the supplier. The fusion protein was eluted from prepa-
rative SDS gels using a mini whole gel eluter (Bio-Rad, Hercules, CA,
USA). Eluted proteins were directly used for immunization of rabbits
using Ribi adjuvant (Sigma, St. Louis, MO, USA). For each injection
we used up to 1 mg of protein. A ¢rst booster injection followed
28 days after the start of the immunization and another 21 days later.
Polyclonal serum was obtained by bleeding the rabbits 2 weeks after
the ¢nal injection. The serum was a⁄nity puri¢ed and the speci¢city
was assessed by Western blot analysis.
2.3. Isolation of GNPDA from mouse tissues and injection into mouse
oocytes
Mouse tissues were isolated, washed once in ice-cold phosphate
bu¡ered saline (PBS), pH 7.4 and cut into small pieces. Single pieces
were immediately frozen in liquid nitrogen. Mouse spermatozoa were
isolated from the epididymis, washed once in PBS, suspended at a
concentration of 109/ml in PBS and frozen in 5^10 Wl aliquots. For
extraction of soluble proteins, tissue or sperm samples were subjected
to three subsequent freeze-thaw cycles followed by centrifugation in a
microfuge (Biofuge, Heraeus, Osterode, Germany) and the superna-
tants containing soluble proteins were used for injection experiments.
The protein concentration was determined using a protein assay kit
(Sigma). SDS-PAGE and Western blot analysis were carried out as
described previously [10].
Stimulation, isolation of oocytes and denudation of oocyte cumulus
complexes followed essentially the protocol described earlier [11], ex-
cept that mice were not mated and isolation occurred at 14 h after
application of human chorionic gonadotropin. For microinjection of
mouse oocytes we applied the protocol given by Rybouchkin et al.
[12] with the modi¢cation that we used HEPES-bu¡ered medium
(Gamete-100, Scandinavian IVF Sciences, Go«teborg, Sweden)
throughout the manipulation procedure. Micromanipulation was per-
formed at an inverted microscope (DMIRB, Leica, Bensheim, Ger-
many) equipped with micromanipulators (Narishige, Tokyo, Japan)
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and using commercial injection needles (Cook, Brisbane, Australia).
The protein concentration of all injection solutions was adjusted to
approximately 50 Wg/Wl. Activation of oocytes was judged from the
presence of a second polar body and the formation of a female pro-
nucleus within 5^7 h after injection [13].
2.4. Immunocytochemistry
Immunocytochemistry was performed on isolated mouse spermato-
cytes and spermatids and on capacitated and acrosome reacted mouse
sperm. Mouse spermatocytes and spermatids were isolated from the
testis essentially as described [14]. Cell suspensions were washed with
PBS, smeared on clean slides and air dried prior to immunocytochem-
istry [10]. Slides were treated with primary antibody (polyclonal rabbit
anti-GNPDA antibody diluted 1:300) or with pre-immune serum for
1 h. Primary antibodies were washed o¡ with PBS and were detected
using a £uorescein-conjugated goat anti-rabbit secondary antibody
(1:100; Sigma). The preparations were washed again and the DNA
was counter-stained with Hoechst 33342 (Sigma). Immuno£uores-
cence microscopy was performed using an inverted microscope
(DMIRB, Leica) equipped with a 100U £uotar objective and appro-
priate ¢lter sets for UV and combined blue/green excitation.
2.5. Capacitation and acrosome reaction
Mouse spermatozoa were isolated from the epididymis [15]. Capaci-
tation and acrosome reaction were performed as described [16]. In
short, spermatozoa were capacitated after isolation by incubation in
culture medium for 2^3 h at 37‡C, 5% CO2. The acrosome reaction
was induced by the addition of calcium ionophore A23817 to 2 WM
and incubation for another 30 min. For immuno£uorescent analysis,
capacitated and acrosome reacted spermatozoa were ¢xed as de-
scribed above. The acrosome reaction was assessed with Pisum sati-
vum lectin coupled to FITC (100 Wg/ml in PBS; Sigma). Detection of
GNPDA followed the protocol given above. For each evaluation at
least 200 spermatozoa were examined.
For Western blot analysis, 20U106 spermatozoa were pelleted after
capacitation and after the acrosome reaction. The culture medium
supernatant was concentrated on 3K size exclusion ¢lter to yield a
minimum amount of medium (20 Wl) which was used for SDS-PAGE.
From the sperm pellet, soluble GNPDA was isolated as described
above. SDS-PAGE and Western blot analysis were performed with
equivalents of 20U106 spermatozoa and corresponding superna-
tant.
3. Results
3.1. Nucleotide and amino acid sequence of mouse GNPDA
The nucleotide sequence and the deduced amino acid se-
quence of the mouse GNPDA are shown in Fig. 1. The iso-
lated cDNA clone was 2249 bp in length and contained an
open reading frame starting from position 53 to 923. A com-
parison of mouse GNPDA based on published amino acid
sequences revealed 14 amino acid changes to human and 10
to hamster GNPDA.
3.2. Presence and location of GNPDA
SDS-Page and Western blot analysis from soluble protein
extracts prepared from mouse brain, kidney, liver, muscle,
ovary, testis and sperm revealed the presence of soluble
GNPDA protein in all examined mouse tissues. The size of
the stained protein amounted to 33 kDa, except for brain
tissue where an additional band occurred at 66 kDa probably
due to protein dimerization (Fig. 2). The amount of GNPDA
was much greater in tissues than in spermatozoa. We injected
cytosol derived from mouse liver, testis or spermatozoa. Acti-
vation and pronuclear formation only occurred with cytosol
from spermatozoa (11 oocytes activated out of 12 which sur-
vived the injection procedure; 92%) and from testis (8/12;
67%) but not with cytosol derived from liver (0/11; 0%).
Fig. 1. The complete nucleotide sequence of mouse GNPDA cDNA and its deduced amino acid sequence are shown. The coding region starts
at position 53 and ends at position 923. The sequence data have been deposited in the GenBank database under accession number AF088903.
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We investigated the localization of GNPDA in isolated tes-
ticular cells by immuno£uorescence. This study revealed a
weak staining in the cytoplasm of isolated spermatocytes
(Fig. 3A,B) and a stronger staining at a distinct site in isolated
spermatids (Fig. 3C,D and E,F). Although we could not per-
form a double immuno£uorescent staining with an anti-acro-
somal antibody, the localization of GNPDA in isolated sper-
matids seemed to be close to the developing acrosomal vesicle
(Fig. 3E,F). Pre-immune serum tested negative (data not
shown).
3.3. Location of GNPDA in capacitated versus acrosome
reacted spermatozoa
Next we examined the presence and localization of
GNPDA in capacitated versus acrosome reacted mouse sper-
matozoa derived from the caput and cauda epididymidis. In
capacitated spermatozoa, over 80% (165/200) spermatozoa
presented with an intact acrosome as revealed by staining
with FITC-labeled Pisum sativum lectin (Fig. 4A,B). Immuno-
£uorescent detection of GNPDA showed in over 70% (142/
200) of spermatozoa a positive reaction at an intracytoplasmic
site neighboring the acrosome (Fig. 4C,D). Following the in-
duction of the acrosome reaction by Ca2 ionophore, 75%
(150/200) of spermatozoa reacted (Fig. 4E,F) and no longer
showed a reaction with the FITC lectin. In over 60% (135/200)
of spermatozoa we noted a weak immuno£uorescence with
the anti-GNPDA antiserum (Fig. 4G,H) and in the remaining
spermatozoa GNPDA could no longer be detected (not
shown). We therefore performed a corresponding Western
blot analysis of capacitated and acrosome reacted spermato-
zoa and especially investigated the presence of soluble
GNPDA in the culture supernatants. During capacitation,
GNPDA was only detected in the spermatozoa and was ab-
sent from the culture medium (Fig. 5, lanes 1,2). Following
induction of the acrosome reaction, GNPDA was found in
spermatozoa as well as in the supernatant, indicative for a
release of GNPDA from spermatozoa (Fig. 5, lanes 3,4).
4. Discussion
In this paper we report the sequence of mouse GNPDA
cDNA clone. Our analysis shows that mouse GNPDA is the
homologue to hamster oscillin and similarly exhibits a strik-
ingly high sequence homology to all mammalian GNPDA
sequences reported so far. Using a polyclonal antibody pro-
duced against a part of mouse GNPDA, we found soluble
mouse GNPDA to be present in all examined tissues. This
Fig. 2. Presence of GNPDA in di¡erent mouse tissues (Br = brain,
Li = liver, Lu = lung, Mu = muscle, Ov = ovary, Te = testis, Sp = sper-
matozoa; C = Control: Sp reacted with secondary antibody alone).
For each lane we used 20 Wg of protein extract, except for sperma-
tozoa, where the proteins derived from 10U106 spermatozoa were
used, which is equivalent to 50 Wg of total protein. The presence of
33 kDa GNPDA can be detected in every tissue. In brain an addi-
tional band at approximately 66 kDa is present which is reduced in
intensity at higher concentrations of DTT or L-mercaptoethanol in
the loading bu¡er.
Fig. 3. Immuno£uorescent localization of GNPDA in isolated testic-
ular cells (A, C, E: GNPDA £uorescence; B, D, F: DNA staining).
Spermatocytes (A, B) show a weak reaction in the cytoplasm. In
spermatids GNPDA is predominantly located at a distinct cytoplas-
mic site (C^F) close to the nucleus. Bar in F = 4 Wm.
Fig. 4. Fluorescent localization of the acrosome (A, E), GNPDA
(C, G) and corresponding DNA staining (B, D, F, H). In capaci-
tated mouse spermatozoa with intact acrosome (A, B), GNPDA is
localized underneath the acrosome (C, D). Following the induction
of the acrosome reaction (E, F), GNPDA £uorescence is either re-
duced and distributed over the entire sperm head (G, H) or absent
(not shown). Bar in H = 4 Wm.
Fig. 5. Western blot analysis of the presence of GNPDA in capaci-
tated (lanes 1, 2) and in acrosome reacted (lanes 3, 4) spermatozoa.
In capacitated spermatozoa, GNPDA was only detected in the
sperm pellet (lane 1) but not in the culture medium supernatant
(lane 2). In acrosome reacted spermatozoa GNPDA was found in
the sperm pellet and in the supernatant. In each lane the protein
equivalent of 20U106 spermatozoa was used for SDS-PAGE and
Western blot analysis.
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¢nding is in contrast to the data presented in the initial paper
on mammalian GNPDA [6], where GNPDA was only de-
tected in the testis and was absent in liver. Mouse extracts
from liver did not activate mouse oocytes after injection,
whereas extracts prepared from spermatozoa and from testis
did. These ¢ndings are in accordance with recently published
work which showed that cloned hamster and human GNPDA
did not exhibit oscillogen activity following expression in ei-
ther prokaryotic or eukaryotic cells and injection into mouse
oocytes [7^9]. Altogether, these data provide strong evidence
that GNPDA, although it is a soluble sperm factor, might not
be responsible for the oscillogen activity known to be present
in sperm cytosol.
However, the role of sperm GNPDA is still unsolved.
GNPDA catalyzes the formation of fructose 6-phosphate
and ammonia from glucosamine 6-phosphate [17] and conse-
quently Wollosker et al. [7] proposed that it may function as
an energy source for sperm motility. This explanation seems
to be unlikely, because GNPDA is localized within the cytosol
of the sperm head, whereas the motor for sperm motility is
located behind the sperm head. We propose that GNPDA
plays a role within the cascade which leads to the initiation
and completion of the acrosome reaction. During spermatid
di¡erentiation, GNPDA co-localizes to a region which resem-
bles the developing acrosome vesicle. In di¡erentiated sperma-
tozoa, GNPDA is located close to the acrosome. Even more
important, the localization of GNPDA can be changed by the
induction of the acrosome reaction. In acrosome reacted sper-
matozoa, GNPDA immuno£uorescence was either weak or
completely absent. This observation and the presence of
GNPDA in the medium supernatant of acrosome reacted
spermatozoa support the idea that soluble GNPDA is released
from spermatozoa during the acrosome reaction.
Therefore, GNPDA might serve as an indicator for the
integrity of the sperm acrosome. We showed recently that
an equatorial localization of GNPDA in human spermatozoa
might correlate with the ability to initiate fertilization after
intracytoplasmic sperm injection (ICSI). Patients with sperma-
tozoa showing mainly an equatorial distribution of GNPDA
had higher fertilization rates compared to patients with
GNPDA predominantly dispersed over the whole sperm
head [10]. In human spermatozoa we only occasionally found
spermatozoa with complete absence of GNPDA immunoreac-
tivity. In view of the data presented in this paper, we may
conclude that in the human, spermatozoa showing a localiza-
tion nother than equatorial might have undergone the acro-
some reaction. This situation would compare with the rear-
rangement and loss of GNPDA observed in acrosome reacted
mouse spermatozoa. In the natural course of fertilization, the
acrosome reaction is initiated prior to fusion of the sperma-
tozoon with the oocyte [18]. In ICSI, which is a major treat-
ment modality for severe male factor subfertility [19,20], ini-
tiation of the acrosome reaction does not occur because the
spermatozoon is injected directly into the ooplasm. In view of
our previous results [10] it is tempting to speculate that sper-
matozoa which underwent the acrosome reaction a long time
prior to injection might have lost not only acrosomal proteins
and GNPDA but also other soluble sperm proteins. If this
included the oocyte activating soluble sperm oscillogen, these
spermatozoa would be not able to initiate successful fertiliza-
tion of an oocyte.
In conclusion, our data indicate that GNPDA in sperma-
tozoa may play a role during the acrosome reaction. Further
investigations are necessary to elucidate the involvement of
GNPDA in the biochemical course and organization of the
acrosome reaction cascade.
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